JP2018150270A - αMSH(1-8) EXPRESSION INHIBITORS - Google Patents
αMSH(1-8) EXPRESSION INHIBITORS Download PDFInfo
- Publication number
- JP2018150270A JP2018150270A JP2017046987A JP2017046987A JP2018150270A JP 2018150270 A JP2018150270 A JP 2018150270A JP 2017046987 A JP2017046987 A JP 2017046987A JP 2017046987 A JP2017046987 A JP 2017046987A JP 2018150270 A JP2018150270 A JP 2018150270A
- Authority
- JP
- Japan
- Prior art keywords
- pentagalloyl
- glucopyranose
- extract
- acid
- whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 title claims abstract description 59
- 239000003112 inhibitor Substances 0.000 title claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 56
- 239000002537 cosmetic Substances 0.000 claims abstract description 15
- 235000013305 food Nutrition 0.000 claims abstract description 12
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 11
- 241000736199 Paeonia Species 0.000 claims description 76
- 239000000284 extract Substances 0.000 claims description 76
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 75
- QJYNZEYHSMRWBK-NIKIMHBISA-N Penta-O-galloyl-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(O)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(O)C(O)=C(O)C=2)=C1 QJYNZEYHSMRWBK-NIKIMHBISA-N 0.000 claims description 59
- 230000002087 whitening effect Effects 0.000 claims description 25
- 230000008099 melanin synthesis Effects 0.000 claims description 11
- 239000004480 active ingredient Substances 0.000 claims description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 10
- 230000003061 melanogenesis Effects 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 description 61
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- 238000009472 formulation Methods 0.000 description 28
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 22
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 22
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 22
- 229960002216 methylparaben Drugs 0.000 description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- -1 alkali metal salts Chemical class 0.000 description 18
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 16
- 108010069820 Pro-Opiomelanocortin Proteins 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 239000003205 fragrance Substances 0.000 description 13
- 108090000765 processed proteins & peptides Proteins 0.000 description 13
- 235000011187 glycerol Nutrition 0.000 description 12
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 229920012196 Polyoxymethylene Copolymer Polymers 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 11
- 210000004209 hair Anatomy 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229920002125 Sokalan® Polymers 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 8
- 239000006210 lotion Substances 0.000 description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 240000007594 Oryza sativa Species 0.000 description 7
- 235000007164 Oryza sativa Nutrition 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 235000015165 citric acid Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- 235000009566 rice Nutrition 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 101800000414 Corticotropin Proteins 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 6
- 229960000258 corticotropin Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 210000002510 keratinocyte Anatomy 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 6
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 6
- 229960003415 propylparaben Drugs 0.000 description 6
- 239000008117 stearic acid Substances 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
- 102000001400 Tryptase Human genes 0.000 description 5
- 108060005989 Tryptase Proteins 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000001641 gel filtration chromatography Methods 0.000 description 4
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940075468 lauramidopropyl betaine Drugs 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 229940043375 1,5-pentanediol Drugs 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 3
- 241000972773 Aulopiformes Species 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 3
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 3
- 101800000520 Melanotropin gamma Proteins 0.000 description 3
- 239000000683 Pro-Opiomelanocortin Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 3
- 229940043264 dodecyl sulfate Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 235000019515 salmon Nutrition 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 239000011732 tocopherol Substances 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 229930003799 tocopherol Natural products 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 239000000055 Corticotropin-Releasing Hormone Substances 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- 229930064664 L-arginine Natural products 0.000 description 2
- 235000014852 L-arginine Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 2
- 101710200814 Melanotropin alpha Proteins 0.000 description 2
- YFGBQHOOROIVKG-FKBYEOEOSA-N Met-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 YFGBQHOOROIVKG-FKBYEOEOSA-N 0.000 description 2
- 108010042237 Methionine Enkephalin Proteins 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 241000237509 Patinopecten sp. Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 102000008314 Type 1 Melanocortin Receptor Human genes 0.000 description 2
- 108010021428 Type 1 Melanocortin Receptor Proteins 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000013040 bath agent Substances 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- SWQUTKGVXGTROS-UHFFFAOYSA-N bis(2-ethoxyethyl) butanedioate Chemical compound CCOCCOC(=O)CCC(=O)OCCOCC SWQUTKGVXGTROS-UHFFFAOYSA-N 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940081733 cetearyl alcohol Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940119676 diethoxyethyl succinate Drugs 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 210000000720 eyelash Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 229940100608 glycol distearate Drugs 0.000 description 2
- 239000000118 hair dye Substances 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 229940057874 phenyl trimethicone Drugs 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011403 purification operation Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 235000020637 scallop Nutrition 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 239000008257 shaving cream Substances 0.000 description 2
- 210000004511 skin melanocyte Anatomy 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- DUHIKWRPAQIIBL-UHFFFAOYSA-N tris(2-ethylhexyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCC(CC)COC(=O)CC(O)(C(=O)OCC(CC)CCCC)CC(=O)OCC(CC)CCCC DUHIKWRPAQIIBL-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- MKLBZEFCSOAOQB-JTQLQIEISA-N (4S)-4-amino-5-octanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O MKLBZEFCSOAOQB-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GDVRUDXLQBVIKP-HQHREHCSSA-N 1-O-galloyl-beta-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-HQHREHCSSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ZYDMZKPAPSZILB-WKNDHWIVSA-N 53917-42-3 Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCNC(N)=N)C(C)C)C(C)C)C1=CC=CC=C1 ZYDMZKPAPSZILB-WKNDHWIVSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000962514 Alosa chrysochloris Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 241000448280 Elates Species 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241000272185 Falco Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 102400000742 Lipotropin beta Human genes 0.000 description 1
- 102400000746 Lipotropin gamma Human genes 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 101800000992 Melanocyte-stimulating hormone beta Proteins 0.000 description 1
- 102400000747 Melanocyte-stimulating hormone beta Human genes 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 101710129905 Melanotropin beta Proteins 0.000 description 1
- 102400000744 Melanotropin gamma Human genes 0.000 description 1
- PQPMMGQTRQFSDA-SRVKXCTJSA-N Met-Glu-His Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O PQPMMGQTRQFSDA-SRVKXCTJSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- XXBXDAPNXSZAMH-UHFFFAOYSA-N [2,2-dimethyl-3-(3,5,5-trimethylhexanoyloxy)propyl] 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CC(=O)OCC(C)(C)COC(=O)CC(C)CC(C)(C)C XXBXDAPNXSZAMH-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010042362 beta-Lipotropin Proteins 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940031020 bis-ethoxydiglycol succinate Drugs 0.000 description 1
- MGQKBAKCRHGMEI-UHFFFAOYSA-N bis[2-(2-ethoxyethoxy)ethyl] butanedioate Chemical compound CCOCCOCCOC(=O)CCC(=O)OCCOCCOCC MGQKBAKCRHGMEI-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- PSHRANCNVXNITH-UHFFFAOYSA-N dimethylamino acetate Chemical compound CN(C)OC(C)=O PSHRANCNVXNITH-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- WODOUQLMOIMKAL-FJSYBICCSA-L disodium;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O WODOUQLMOIMKAL-FJSYBICCSA-L 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108010075816 gamma-Lipotropin Proteins 0.000 description 1
- 229940108690 glucosyl hesperidin Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 210000002184 nasal cartilage Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003214 pyranose derivatives Chemical class 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000008256 whipped cream Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- SFVVQRJOGUKCEG-OPQSFPLASA-N β-MSH Chemical compound C1C[C@@H](O)[C@H]2C(COC(=O)[C@@](O)([C@@H](C)O)C(C)C)=CCN21 SFVVQRJOGUKCEG-OPQSFPLASA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- GZWUQPQBOGLSIM-VOOUCTBASA-N γ msh Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C(C)C)C1=CC=C(O)C=C1 GZWUQPQBOGLSIM-VOOUCTBASA-N 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、紫外線やストレスによって産生されるセリン、チロシン、セリン、メチオニン、グルタミン酸、ヒスチジン、フェニルアラニン、アルギニンの配列順で構成される8つのアミノ酸から成るペプチド(以下、αMSH(1−8)と記載)発現抑制剤又はメラニン産生阻害組成剤、及び美白用化粧料組成物、美白用食品組成物、美白用医薬品組成物の利用に関するものである。 The present invention describes a peptide composed of eight amino acids (hereinafter referred to as αMSH (1-8)) composed of serine, tyrosine, serine, methionine, glutamic acid, histidine, phenylalanine, and arginine, which are produced by ultraviolet rays and stress. ) Expression inhibitors or melanin production inhibiting compositions, and whitening cosmetic compositions, whitening food compositions, and whitening pharmaceutical compositions.
プロオピオメラノコルチン(Pro-opiomelanocortin、以下POMCと記載)は、241個のアミノ酸残基からなるポリペプチド前駆体である。285アミノ酸残基長のポリペプチド前駆体であるプレプロオピオメラノコルチン(pre-POMC)から、翻訳後プロセッシングにて44アミノ酸残基長のシグナルペプチド配列が切除されプPOMCとなる。POMCは主に下垂体の前葉と中葉で産生されるが、皮膚組織等からも産生されており、紫外線などの刺激によってPOMCの産生量が増加することも知られている(非特許文献1参照)。 Pro-opiomelanocortin (hereinafter referred to as POMC) is a polypeptide precursor composed of 241 amino acid residues. A signal peptide sequence having a length of 44 amino acid residues is excised from preproopiomelanocortin (pre-POMC), which is a polypeptide precursor having a length of 285 amino acid residues, by post-translational processing to form POMC. POMC is mainly produced in the anterior and middle lobes of the pituitary gland, but it is also produced from skin tissues and the like, and it is also known that the production amount of POMC is increased by stimulation with ultraviolet rays or the like (see Non-Patent Document 1). ).
また、POMC内には、プロセッシングによって切断可能な箇所があり、組織や変換酵素によって次に示す最大10の活性ペプチドが産生される。その10の活性ペプチドとしては、N−ターミナル ペプチド プロオピオメラノコルチン(Terminal Peptide of Proopiomelanocortin,NPP or pro-γ-MSH) 、γ-メラノサイト細胞刺激ホルモン(γ-melanocyte-stimulating hormone,γ-MSH)、副腎皮質刺激ホルモン(adrenocorticotropic hormone,ACTH)、α−メラノサイト細胞刺激ホルモン(α‐melanocyte stimulating hormone,α-MSH)、コルチコトロピン様中葉ペプチド(Corticotropin-like Intermediate Peptide,CLIP)、β−リポトロピン(β‐lipotropic hormone,β-LPH)、γ-リポトロピン(γ‐lipotropic hormone,γ-LPH)、β−メラノサイト細胞刺激ホルモン(β-melanocyte stimulating hormone,β-MSH)、β−エンドルフィン(β-Endorphin)メチオニン−エンケファリン(methionine-enkephalin)である。 In addition, there are portions in POMC that can be cleaved by processing, and up to 10 active peptides shown below are produced by tissues and converting enzymes. The 10 active peptides include N-terminal peptide proopiomelanocortin (NPP or pro-γ-MSH), γ-melanocyte-stimulating hormone (γ-MSH), adrenal gland Corticotropin (adrenocorticotropic hormone, ACTH), α-melanocyte stimulating hormone (α-MSH), corticotropin-like intermediate peptide (CLIP), β-lipotropic hormone (β-lipotropic hormone , Β-LPH), γ-lipotropic hormone (γ-LPH), β-melanocyte stimulating hormone (β-MSH), β-endorphin methionine-enkephalin ( methionine-enkephalin).
また、副腎皮質刺激ホルモンがさらにプロセッシングを受けて産生されるα−メラノサイト細胞刺激ホルモンは、メラニン産生を誘導するホルモンとして広く知られている。ストレス応答に関わる副腎皮質刺激ホルモンから誘導されるホルモンであるが、一般的な皮膚科学としては紫外線によって誘導されるメラニン合成ホルモンとして認知されている。一方、角化細胞が分泌するα−MSHは低濃度であり、多くは細胞内プロセッシングを受けていないPOMCの状態で高濃度に分泌していることが報告されている。 Further, α-melanocyte stimulating hormone produced by further processing of adrenocorticotropic hormone is widely known as a hormone that induces melanin production. Although it is a hormone derived from adrenocorticotropic hormone involved in stress response, it is recognized as a melanin-synthesizing hormone induced by ultraviolet rays in general dermatology. On the other hand, α-MSH secreted by keratinocytes has a low concentration, and many are reported to be secreted at a high concentration in the state of POMC not subjected to intracellular processing.
我々は、マウスの皮膚に紫外線を照射するとPOMCだけでなく、トリプシン様酵素によりPOMCからαMSH(1−8)が細胞外プロセッシングにより生成することを見出した(非特許文献2参照)。また、このペプチドは、文献によってはACTH(1−8)と表記される場合もあるが同一のペプチドである。 We have found that αMSH (1-8) is generated by extracellular processing from POMC not only by POMC but also by trypsin-like enzyme when the skin of mice is irradiated with ultraviolet rays (see Non-Patent Document 2). Moreover, although this peptide may be described as ACTH (1-8) depending on literature, it is the same peptide.
従来から知られているPOMCプロセッシング活性ペプチドは、ケラチノサイトの中でプロセッシングされたものが、個々に活性ペプチドとしてケラチノサイトから分泌されている。一方、αMSH(1−8)は、POMCとしてケラチノサイト外に分泌された後に、細胞外プロセッシングによって生成される。このことから、αMSH(1−8)は既存のシステムとは全く異なる合成経路によって生成される新規の活性ペプチドであるといえる。さらに、POMCからαMSH(1−8)をプロセッシングする因子として、セリンプロテアーゼの1種であるトリプターゼが特定されている(非特許文献3、非特許文献4参照)。 Conventionally known POMC processing active peptides, which are processed in keratinocytes, are individually secreted from keratinocytes as active peptides. On the other hand, αMSH (1-8) is produced by extracellular processing after being secreted outside keratinocytes as POMC. From this, it can be said that αMSH (1-8) is a novel active peptide produced by a synthetic route completely different from the existing system. Furthermore, tryptase, which is a kind of serine protease, has been identified as a factor for processing αMSH (1-8) from POMC (see Non-patent Documents 3 and 4).
また、このαMSH(1−8)がメラノサイトのMC1レセプターに結合し、メラニン産生を誘導することを明らかとしており(非特許文献3参照)、我々はヒメフウロ抽出物に優れたαMSH(1−8)産生抑制効果、メラニン生成阻害効果を既に見出している(特許文献1参照)。 In addition, it has been clarified that this αMSH (1-8) binds to the MC1 receptor of melanocytes and induces melanin production (see Non-Patent Document 3). Production suppression effects and melanin production inhibition effects have already been found (see Patent Document 1).
このように、αMSH(1−8)がメラニン産生経路に深く関わることは明かであるが、このペプチドの存在は生化学的にも新しい知見であり、現在も様々な研究がなされている状況である。例えば、このペプチドは紫外線によって誘導されることから、紫外線に始まる、体内のあらゆる反応のセンサーとして機能している可能性が高い。すなわち、免疫機能の調整や、しわやたるみ乾燥による皮膚老化の因子としての作用が考えられる。 Thus, it is clear that αMSH (1-8) is deeply involved in the melanin production pathway, but the existence of this peptide is a new biochemical finding, and various researches are currently being conducted. is there. For example, since this peptide is induced by ultraviolet rays, it is highly likely that it functions as a sensor for all reactions in the body starting with ultraviolet rays. That is, it can be considered to act as a factor of skin aging due to adjustment of immune function and drying of wrinkles and sagging.
(非特許文献1)Aline Primot,Elena Sviderskaya,et al:THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol.279,No.49,:pp.51226-51233(2004)
(非特許文献2)山根、山本ら:日本薬学会 第130年会 28SJ−pm15 要旨集3−101頁
(非特許文献3)大石、山本ら:日本薬学会 第131年会 30P―0070 要旨集3−118頁
(非特許文献4)Yamamoto et al:Sci Rep、2015 Sep 29;5:14579
(Non-Patent Document 1) Aline Primot, Elena Sviderskaya, et al: THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol.279, No.49,: pp.51226-51233 (2004)
(Non-Patent Document 2) Yamane, Yamamoto et al .: The 130th Annual Meeting of the Japanese Pharmaceutical Society, 28SJ-pm15, p. 3-101 (Non-patent Document 3) Oishi, Yamamoto et al. 3-118 (Non-patent Document 4) Yamamoto et al: Sci Rep, 2015 Sep 29; 5: 14579
(特許文献1)特開2015−137267 (Patent Document 1) JP-A-2015-137267
本発明の課題は、新規なαMSH(1−8)発現抑制剤、メラニン産生阻害組成剤、及び美白用化粧料組成物、美白用食品組成物、美白用医薬品組成物を提供することである。 An object of the present invention is to provide a novel αMSH (1-8) expression inhibitor, a melanin production inhibitor, a whitening cosmetic composition, a whitening food composition, and a whitening pharmaceutical composition.
本発明者らは前記課題を解決するため、多数の植物抽出物に対してαMSH(1−8)発現抑制試験を行い、有効性を確認した。その結果、シャクヤク抽出物およびシャクヤク抽出物に含まれるペンタガロイルグルコースに高いαMSH(1−8)発現抑制効果を見出した。 In order to solve the above-mentioned problems, the present inventors conducted αMSH (1-8) expression suppression tests on a large number of plant extracts and confirmed the effectiveness. As a result, a high αMSH (1-8) expression inhibitory effect was found on peony extract and pentagalloylglucose contained in peony extract.
シャクヤク抽出物、ペンタガロイルグルコピラノースは、紫外線やストレスを受けることによって体内中で産生されるαMSH(1−8)の産生を抑制する。αMSH(1−8)は、メラノサイトのMC1レセプターに結合しメラニン産生を誘導することから、αMSH(1−8)発現抑制作用を示したシャクヤク抽出物、ペンタガロイルグルコピラノースは特に皮膚の美白、しみ・そばかすの予防、改善を目的とするαMSH(1−8)発現抑制剤、メラニン産生阻害組成剤、及び美白用化粧料組成物、美白用食品組成物、美白用医薬品組成物に用いられる。 The peony extract, pentagalloyl glucopyranose, suppresses the production of αMSH (1-8) produced in the body by receiving ultraviolet rays and stress. Since αMSH (1-8) binds to the MC1 receptor of melanocytes and induces melanin production, the peony extract, pentagalloylglucopyranose, which showed αMSH (1-8) expression inhibitory action, is particularly whitening of the skin, It is used for αMSH (1-8) expression inhibitor, melanin production inhibiting composition, whitening cosmetic composition, whitening food composition, and whitening pharmaceutical composition for the purpose of prevention and improvement of spots and freckles.
尚、本発明で使用する「シャクヤク」とは、ボタン科(Paeoniaceae)、ボタン属(Paeonia)、の植物:シャクヤク(Paeonia lactiflora)を用いる。 The “peony” used in the present invention is a plant of the family Paeoniaceae and Paeonia: Paeonia lactiflora.
本発明で使用するシャクヤク抽出物はシャクヤクの部位として根を利用することが好ましいが、この他、花、葉、種子等から選ばれる1種又は2種以上を用いることが出来る。また抽出物は、これら各種の抽出部位から溶媒を用いて直接抽出することで得られるものの他、圧搾処理を施した後に得られる圧搾液及び/又は残渣に溶媒を加えて抽出することで得られるものも、本発明における抽出物の定義の範囲に含まれる。 The peonies extract used in the present invention preferably uses roots as peonies, but in addition, one or more selected from flowers, leaves, seeds and the like can be used. Moreover, an extract is obtained by adding a solvent to the pressing liquid and / or residue obtained after performing a pressing process other than what is obtained by extracting directly from these various extraction parts using a solvent. Are also included within the scope of the definition of extract in the present invention.
抽出方法については、その溶媒の温度や原料に対する溶媒の重量比率、又は抽出時間についても、種々の原料及び使用する溶媒に対しそれぞれを任意に設定することができる。溶媒の温度としては−4℃から100℃の範囲で任意に設定できるが、原料中に含まれる成分の安定性の点から、10〜40℃付近が好ましい。又、原料に対する溶媒の重量比率も、例えば原料:溶媒が、4:1〜1:100の範囲内で任意に設定することができ、特に1:1〜1:20の重量比率が好ましい。 Regarding the extraction method, the temperature of the solvent, the weight ratio of the solvent to the raw material, or the extraction time can be arbitrarily set for various raw materials and the solvent used. Although it can set arbitrarily as the temperature of a solvent in the range of -4 degreeC to 100 degreeC, 10-40 degreeC vicinity is preferable from the point of stability of the component contained in a raw material. Also, the weight ratio of the solvent to the raw material can be arbitrarily set, for example, in the range of the raw material: solvent 4: 1 to 1: 100, and the weight ratio of 1: 1 to 1:20 is particularly preferable.
本発明で使用するシャクヤク抽出物は、溶媒抽出後、更に適宜精製操作を施すことも可能であり、精製操作としては、酸(塩酸、硫酸、硝酸、リン酸、有機酸等)又はアルカリ(水酸化ナトリウム、水酸化カルシウム、アンモニア等)添加による分解、微生物による発酵又は代謝変換、イオン交換樹脂や活性炭、ケイ藻土等による成分吸着、種々の分離モード(イオン交換、親水性吸着、疎水性吸着、サイズ排除、配位子交換、アフィニティー等)を有するクロマトグラフィーを用いた分画、濾紙やメンブランフィルター、限外濾過膜等を用いた濾過、加圧又は減圧、加温又は冷却、乾燥、pH調整、脱臭、脱色、長時間の静置保管等が例示でき、これらを任意に選択し組合わせた処理を行うことが可能である。 The peony extract used in the present invention can be further subjected to a purification operation after solvent extraction. The purification operation includes acid (hydrochloric acid, sulfuric acid, nitric acid, phosphoric acid, organic acid, etc.) or alkali (water). Decomposition by adding sodium oxide, calcium hydroxide, ammonia, etc., fermentation or metabolic conversion by microorganisms, component adsorption by ion exchange resin, activated carbon, diatomaceous earth, etc., various separation modes (ion exchange, hydrophilic adsorption, hydrophobic adsorption) Fractionation using chromatography with size exclusion, ligand exchange, affinity, etc.), filtration using filter paper, membrane filter, ultrafiltration membrane, etc., pressurization or decompression, heating or cooling, drying, pH Examples include adjustment, deodorization, decolorization, and long-term stationary storage, and it is possible to arbitrarily select and combine them.
本発明で用いる次の化学構造式(化1)で示されるペンタガロイルグルコピラノースは植物、動物、菌体等から抽出、合成等から得ることが出来、シャクヤクがペンタガロイルグルコピラノースを多く含むため、そこからカラム等を用いて精製を用いてもよい。また、通常医薬、化粧料で用いられているアルカリと反応させて塩と為すことも出来る。この様な塩としては、例えば、ナトリウム塩、カリウム塩等のアルカリ金属塩、カルシウム塩、マグネシウム塩等のアルカリ土類金属塩、アンモニウム塩、トリエタノールアミン塩、トリエチルアミン塩等の有機アミン塩類、リジン塩、アルギニン塩等の塩基性アミノ酸塩等が好ましく例示できる。
本発明のαMSH(1−8)発現抑制剤、メラニン産生阻害組成剤、美白用化粧料組成物、美白用食品組成物、美白用医薬品組成物を製造する上で、使用するシャクヤク抽出物、ペンタガロイルグルコースの形状としては、液状、固形状、粉末状、ペースト状等いずれの形状でも良く、本発明を実施する上で最適な形状を任意に選択することができる。また、αMSH(1−8)とは「Ser Tyr Ser Met Glu His Phe Arg」の8つのアミノ酸配列からなるペプチドである。 Peonies extract, penta used for producing αMSH (1-8) expression inhibitor, melanin production inhibitor composition, whitening cosmetic composition, whitening food composition, whitening pharmaceutical composition of the present invention The shape of galloylglucose may be any shape such as liquid, solid, powder, paste, etc., and an optimal shape can be arbitrarily selected for carrying out the present invention. ΑMSH (1-8) is a peptide consisting of eight amino acid sequences of “Ser Tyr Ser Met Glu His Phe Arg”.
本発明の各種薬剤、組成物におけるシャクヤク抽出物の含有量としては、本発明の効果を有することが確認できる範囲であれば特に制限はないが、一般的にはシャクヤク抽出物の固形分濃度が、各種組成物中の0.0001〜10質量%、好ましくは0.001〜5質量%の範囲であって、最も好ましくは0.01〜0.1質量%の範囲である。ペンタガロイルグルコースは0.0001〜10重量%であることが好ましく、0.001〜5重量%であることが最も好ましい。 The content of the peony extract in the various drugs and compositions of the present invention is not particularly limited as long as it can be confirmed that the effect of the present invention is obtained, but generally the solid content concentration of the peony extract is In the various compositions, the range is 0.0001 to 10% by mass, preferably 0.001 to 5% by mass, and most preferably 0.01 to 0.1% by mass. The pentagalloyl glucose is preferably 0.0001 to 10% by weight, and most preferably 0.001 to 5% by weight.
本発明のαMSH(1−8)発現抑制剤、メラニン産生阻害剤の利用に関しては、化粧料、食品、医薬品等各種組成物へ利用できる。αMSH(1−8)の発現を抑制できる形態であれば、固体、液体を問わず使用することが出来る。 The αMSH (1-8) expression inhibitor and melanin production inhibitor of the present invention can be used for various compositions such as cosmetics, foods, and pharmaceuticals. Any form that can suppress the expression of αMSH (1-8) can be used regardless of whether it is solid or liquid.
また、本発明による美白用化粧料組成物、美白用医薬品組成物の具体例としてはアンプル、カプセル、丸剤、錠剤、粉末、顆粒、固形、液体、ゲル、気泡、エマルジョン、シート、ミスト、スプレー剤等利用上の適当な形態の1)医薬品類、2)医薬部外品類、3)局所用又は全身用の皮膚用化粧品類(例えば、化粧水、乳液、クリーム、軟膏、ローション、オイル、パック等の基礎化粧料、固形石鹸、液体ソープ、ハンドウォッシュ等の洗顔料や皮膚洗浄料、マッサージ用剤、クレンジング用剤、除毛剤、脱毛剤、髭剃り処理料、アフターシェーブローション、プレショーブローション、シェービングクリーム、ファンデーション、口紅、頬紅、アイシャドウ、アイライナー、マスカラ等のメークアップ化粧料、香水類、美爪剤、美爪エナメル、美爪エナメル除去剤、パップ剤、プラスター剤、テープ剤、シート剤、貼付剤、エアゾール剤等)、4)頭皮・頭髪に適用する薬用又は/及び化粧用の製剤類(例えば、シャンプー剤、リンス剤、ヘアートリートメント剤、プレヘアートリートメント剤、パーマネント液、染毛料、整髪料、ヘアートニック剤、育毛・養毛料、パップ剤、プラスター剤、テープ剤、シート剤、エアゾール剤等)、5)浴湯に投じて使用する浴用剤、6)その他、腋臭防止剤や消臭剤、制汗剤、衛生用品、衛生綿類、ウエットティシュ等が挙げられる。 Specific examples of the whitening cosmetic composition and whitening pharmaceutical composition according to the present invention include ampoules, capsules, pills, tablets, powders, granules, solids, liquids, gels, bubbles, emulsions, sheets, mists and sprays. 1) Pharmaceuticals, 2) Quasi-drugs, 3) Topical or systemic skin cosmetics (eg lotion, milky lotion, cream, ointment, lotion, oil, pack) Such as basic cosmetics such as soap, liquid soap, hand wash, etc., facial cleanser and skin cleanser, massage agent, cleansing agent, hair remover, hair remover, shaving treatment, after-shave lotion, pre-show lotion, Makeup cosmetics such as shaving cream, foundation, lipstick, blusher, eye shadow, eyeliner, mascara, perfume, nail preparation, beauty nail ena 4) Medicinal and / or cosmetic preparations (for example, shampoos) to be applied to the scalp and head hair), nail enamel remover, patch, plaster, tape, sheet, patch, aerosol, etc. , Rinse agents, hair treatment agents, pre-hair treatment agents, permanent liquids, hair dyes, hair styling agents, hair styling agents, hair growth / hair restoration agents, poultices, plaster agents, tape agents, sheet agents, aerosol agents, etc.), 5) Bath agents to be used by bathing, 6) In addition, anti-smell agents, deodorants, antiperspirants, hygiene products, sanitary cotton, wet tissue and the like.
さらに美白用食品組成物、美白用医薬品組成物の具体例としては、清涼飲料、炭酸飲料、栄養飲料、果実飲料、乳酸飲料等の飲料;アイスクリーム、アイスシャーベット、かき氷等の冷菓;そば、うどん、はるさめ、ぎょうざの皮、しゅうまいの皮、中華麺、即席麺等の麺類;飴、キャンディー、ガム、チョコレート、錠菓、スナック菓子、ビスケット、ゼリー、ジャム、クリーム、焼き菓子、パン等の菓子類;カニ、サケ、アサリ、マグロ、イワシ、エビ、カツオ、サバ、クジラ、カキ、サンマ、イカ、アカガイ、ホタテ、アワビ、ウニ、イクラ、トコブシ等の水産物;かまぼこ、ハム、ソーセージ等の水産・畜産加工食品;加工乳、発酵乳等の乳製品;サラダ油、てんぷら油、マーガリン、マヨネーズ、ショートニング、ホイップクリーム、ドレッシング等の油脂及び油脂加工食品;ソース、たれ等の調味料;カレー、シチュー、親子丼、お粥、雑炊、中華丼、かつ丼、天丼、うな丼、ハヤシライス、おでん、マーボドーフ、牛丼、ミートソース、玉子スープ、オムライス、餃子、シューマイ、ハンバーグ、ミートボール等のレトルトパウチ食品;種々の形態の健康食品や栄養補助食品;錠剤、カプセル剤、ドリンク剤、トローチ等の医薬品、医薬部外品が上げられる。 Furthermore, specific examples of the whitening food composition and the whitening pharmaceutical composition include soft drinks, carbonated drinks, nutrition drinks, fruit drinks, lactic acid drinks and other beverages; ice cream, ice sherbet, shaved ice and other frozen desserts; buckwheat, udon , Harusame, Gyoza skin, Suimai skin, Chinese noodles, Instant noodles and other noodles; Sweets such as candy, candy, gum, chocolate, tablet confectionery, snacks, biscuits, jelly, jam, cream, baked goods, bread, etc .; Marine products such as crab, salmon, clam, tuna, sardine, shrimp, skipjack, mackerel, whale, oyster, saury, squid, red scallop, scallop, abalone, sea urchin, salmon roe, tocobushi; fishery and livestock processing such as kamaboko, ham, sausage Food; Dairy products such as processed milk and fermented milk; salad oil, tempura oil, margarine, mayonnaise, shortening, whipped cream , Dressings and other fats and oils and processed foods; sauces, sauces and other seasonings; curry, stew, oyakodon, rice bowls, miscellaneous rice, Chinese rice bowls, and rice bowls, tempura, eel rice, hayashi rice, oden, mabodorf, beef bowl, meat sauce , Egg soup, omelet rice, dumplings, shumai, hamburger, meatballs and other retort pouch foods; various forms of health foods and nutritional supplements; tablets, capsules, drinks, troches and other pharmaceuticals, and quasi drugs It is done.
本発明の美白用化粧料組成物、美白用医薬品組成物には、本発明の効果を損なわない範囲内であれば、エタノール、ブチレングリコールなどの各種アルコール;モノステアリン酸グリセリル、サポニンなどの非イオン性界面活性剤;N−ステアロイル−L−グルタミン酸ナトリウムなどの陰イオン性界面活性剤;N−ヤシ油脂肪酸アシル−L−アルギニンエチル・DL−ピロリドンカルボン酸塩などの陽イオン性界面活性剤;ラウリルジメチルアミノ酢酸ベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタインなどの両性界面活性剤;キサンタンガム、カルボキシビニルポリマーなどの水溶性増粘剤;トコフェロールおよびその誘導体、アスコルビン酸およびその誘導体などのビタミン類;フェノキエタノール、オクトキシグリセリン、パラベンなどの防腐成分;紫外線吸収剤;紫外線散乱剤;無機顔料、パール化剤、植物抽出エキス、金属イオン封鎖剤、香料、pH調整剤などを目的に応じて適宜配合することができる。 The whitening cosmetic composition and the whitening pharmaceutical composition of the present invention include various alcohols such as ethanol and butylene glycol; non-ions such as glyceryl monostearate and saponin, as long as the effects of the present invention are not impaired. Anionic surfactants such as sodium N-stearoyl-L-glutamate; cationic surfactants such as N-coconut oil fatty acid acyl-L-arginine ethyl DL-pyrrolidone carboxylate; lauryl Amphoteric surfactants such as betaine dimethylaminoacetate, 2-alkyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine; water-soluble thickeners such as xanthan gum, carboxyvinyl polymer; tocopherol and its derivatives, ascorbic acid and Vitamins such as its derivatives; Feno Preservative ingredients such as ethanol, octoxyglycerin, paraben; UV absorbers; UV scattering agents; inorganic pigments, pearling agents, plant extracts, sequestering agents, fragrances, pH adjusters, etc. be able to.
また、本発明の美白用食品組成物、美白用医薬品組成物には本発明の効果を損なわない範囲内であれば、ブドウ糖、果糖、ショ糖、マルトース、ソルビトール、ステビオサイド、ルブソサイド、コーンシロップ、乳糖、クエン酸、酒石酸、リンゴ酸、コハク酸、乳酸、L−アスコルビン酸、dl−α−トコフェロール、エリソルビン酸ナトリウム、グリセリン、プロピレングリコール、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、アラビアガム、カラギーナン、カゼイン、ゼラチン、ペクチン、寒天、ビタミンB類、ニコチン酸アミド、パントテン酸カルシウム、アミノ酸類、カルシウム塩類、色素、香料、保存剤などを目的に応じて適宜配合することができる。 In addition, the whitening food composition and whitening pharmaceutical composition of the present invention are within the range that does not impair the effects of the present invention, glucose, fructose, sucrose, maltose, sorbitol, stevioside, rubusoside, corn syrup, lactose , Citric acid, tartaric acid, malic acid, succinic acid, lactic acid, L-ascorbic acid, dl-α-tocopherol, sodium erythorbate, glycerin, propylene glycol, glycerin fatty acid ester, polyglycerin fatty acid ester, sucrose fatty acid ester, sorbitan fatty acid Esters, gum arabic, carrageenan, casein, gelatin, pectin, agar, vitamin B, nicotinamide, calcium pantothenate, amino acids, calcium salts, pigments, fragrances, preservatives, etc. it can.
本発明で用いるシャクヤク抽出物の製造例を以下に詳述するが、本発明の柿葉抽出物は以下の製造例に限定されない。 Although the manufacture example of the peony extract used by this invention is explained in full detail below, the bamboo leaf extract of this invention is not limited to the following manufacture examples.
(製造例1)
シャクヤクの根乾燥物を粉砕し、100gを精製水(約80℃)1.2kgにて約5時間加温抽出し、ろ過してシャクヤク抽出物を約1.0kg(乾燥固形分1%)得た。
(Production Example 1)
The dried peony roots were pulverized and 100 g was heated and extracted with 1.2 kg of purified water (about 80 ° C.) for about 5 hours and filtered to obtain about 1.0 kg of peony extract (dry
(製造例2)
シャクヤクの根乾燥物を粉砕し、100gをエタノール(30%)、1,3−ブチレングリコール(20%)、水(50%)の混液1.2kgに浸漬し、室温にて5昼夜抽出した後、ろ過してシャクヤク抽出物を約1.0kg(乾燥固形分2.3%)得た。
(Production Example 2)
After crushing dried peonies roots, 100 g was immersed in 1.2 kg of a mixture of ethanol (30%), 1,3-butylene glycol (20%) and water (50%) and extracted at room temperature for 5 days and nights. Filtration yielded approximately 1.0 kg of peony extract (dry solids 2.3%).
(製造例3)
シャクヤクの根乾燥物を粉砕し、100gを50%ブチレングリコール溶液1.2kgに浸漬し、室温にてて5昼夜抽出した後、ろ過してシャクヤク抽出物を約1.0kg(乾燥固形分2.1%)得た。
(Production Example 3)
The dried peony roots were pulverized, 100 g was immersed in 1.2 kg of 50% butylene glycol solution, extracted at room temperature for 5 days and nights, and then filtered to obtain about 1.0 kg of peony extract (dry
(製造例4)
シャクヤクの根乾燥物を粉砕し、100gを50%エタノール溶液1.2kgに浸漬し、室温にてて5昼夜抽出した後、ろ過してシャクヤク抽出物を約1.0kg(乾燥固形分2.5%)得た。
(Production Example 4)
The dried peonies roots were pulverized, 100 g was immersed in 1.2 kg of 50% ethanol solution, extracted at room temperature for 5 days and nights, and then filtered to obtain about 1.0 kg of peonies extract (dry solids content 2.5 %)Obtained.
(試験1)シャクヤク抽出物のαMSH(1−8)の発現抑制評価試験
正常ヒト皮膚角化細胞(クラボウ社製)と正常ヒト皮膚メラノサイト(クラボウ社製)を10:1の割合で培養する。細胞に2mJの紫外線(UV−B)を照射後、製造例3、製造例4で製造したシャクヤク抽出物をそれぞれ含有無血清培地(OPTI−MEM、Gibco)にて培養する。24時間後、培養上清を回収し、リコンビナントトリプターゼ(Promega,rhSkin,β−tryptase)を添加して反応させ、トリフルオロ酢酸を添加して反応を停止する、その後既報(Yamamoto et al:Sci Rep、2015 Sep 29;5:14579)に従い、ゲルろ過クロマトグラフィーで粗精製したのち、逆相HPLCで分離、検出し濃度を測定した。以下が分析条件である。
(ゲルろ過クロマトグラフィー)
カラム:Sephadex G-75 fine column(1.0×100cm)
溶媒:1M酢酸
デキストラン換算で1.1kDa付近のフラクションを回収し、HPLCにインジェクトした。
(HPLC)
分析機器:SLC-6B(島津社製)
検出器:SPD-7A
カラム:ODSカラム(4.6×150mm、Myfhtsil RP-GP 5μm、関東化学社製)
流速:1.0mL/min
溶媒:A液:アセトニトリル、B液:0.01M塩酸
グラジエント;
0min;%A液/%B液 = 100/0 → 30min;%A液、%B液 = 40/60
(Test 1) Expression inhibition evaluation test of αMSH (1-8) of peony extract Normal human skin keratinocytes (Kurabo) and normal human skin melanocytes (Kurabo) are cultured at a ratio of 10: 1. After irradiating the cells with 2 mJ of ultraviolet light (UV-B), the peony extract produced in Production Example 3 and Production Example 4 is cultured in a serum-free medium (OPTI-MEM, Gibco). After 24 hours, the culture supernatant was collected, reacted by adding recombinant tryptase (Promega, rhSkin, β-tryptase), and stopped by adding trifluoroacetic acid. Then, Yamamoto et al: Sci Rep , 2015 Sep 29; 5: 14579), and then roughly purified by gel filtration chromatography, separated and detected by reverse phase HPLC, and the concentration was measured. The analysis conditions are as follows.
(Gel filtration chromatography)
Column: Sephadex G-75 fine column (1.0 × 100cm)
Solvent: A fraction near 1.1 kDa in terms of 1M dextran acetate was collected and injected into HPLC.
(HPLC)
Analytical instrument: SLC-6B (Shimadzu)
Detector: SPD-7A
Column: ODS column (4.6 x 150 mm, Myfhtsil RP-
Flow rate: 1.0 mL / min
Solvent: Liquid A: Acetonitrile, Liquid B: 0.01 M hydrochloric acid gradient;
0 min;% A solution /% B solution = 100/0 → 30 min;% A solution,% B solution = 40/60
(試験結果)
図1は製造例3で製造したシャクヤク抽出物を添加した試験1の結果、図2は製造例4で製造したシャクヤク抽出物を添加した試験1の結果である。いずれのシャクヤク抽出物にはαMSH(1−8)の発現抑制効果がみられたが、特に製造例4によるシャクヤク抽出物の効果が高く、有効成分を分画していったところペンタガロイルグルコピラノースが多く含まれていることが分かった。また、製造例1、製造例2においても製造例4よりは低いがαMSH(1−8)の発現抑制効果がみられた。
(Test results)
FIG. 1 shows the results of
(試験2)ペンタガロイルグルコピラノースのαMSH(1−8)の発現抑制評価試験
正常ヒト皮膚角化細胞(クラボウ社製)と正常ヒト皮膚メラノサイト(クラボウ社製)を10:1の割合で培養する。細胞に2mJの紫外線(UV−B)を照射後、ペンタガロイルグルコピラノース(フナコシ社製)含有無血清培地(OPTI−MEM、Gibco)にて培養する。24時間後、培養上清を回収し、リコンビナントトリプターゼ(Promega,rhSkin,β−tryptase)を添加して反応させ、トリフルオロ酢酸を添加して反応を停止する、その後既報(Yamamoto et al:Sci Rep、2015 Sep 29;5:14579)に従い、ゲルろ過クロマトグラフィーで粗精製したのち、逆相HPLCで分離、検出し濃度を測定した。以下が分析条件である。
(ゲルろ過クロマトグラフィー)
カラム:Sephadex G-75 fine column(1.0×100cm)
溶媒:1M酢酸
デキストラン換算で1.1kDa付近のフラクションを回収し、HPLCにインジェクトした。
(HPLC)
分析機器:SLC-6B(島津社製)
検出器:SPD-7A
カラム:ODSカラム(4.6×150mm、Myfhtsil RP-GP 5μm、関東化学社製)
流速:1.0mL/min
溶媒:A液:アセトニトリル、B液:0.01M塩酸
グラジエント;
0min;%A液/%B液 = 100/0 → 30min;%A液、%B液 = 40/60
(Test 2) Expression inhibition evaluation test of αMSH (1-8) of pentagalloylglucopyranose Normal human skin keratinocytes (Kurabo) and normal human skin melanocytes (Kurabo) were cultured at a ratio of 10: 1. To do. The cells are irradiated with 2 mJ ultraviolet rays (UV-B) and then cultured in a serum-free medium (OPTI-MEM, Gibco) containing pentagalloylglucopyranose (Funakoshi). After 24 hours, the culture supernatant was collected, reacted by adding recombinant tryptase (Promega, rhSkin, β-tryptase), and stopped by adding trifluoroacetic acid. Then, Yamamoto et al: Sci Rep , 2015 Sep 29; 5: 14579), and then roughly purified by gel filtration chromatography, separated and detected by reverse phase HPLC, and the concentration was measured. The analysis conditions are as follows.
(Gel filtration chromatography)
Column: Sephadex G-75 fine column (1.0 × 100cm)
Solvent: A fraction near 1.1 kDa in terms of 1M dextran acetate was collected and injected into HPLC.
(HPLC)
Analytical instrument: SLC-6B (Shimadzu)
Detector: SPD-7A
Column: ODS column (4.6 x 150 mm, Myfhtsil RP-
Flow rate: 1.0 mL / min
Solvent: Liquid A: Acetonitrile, Liquid B: 0.01 M hydrochloric acid gradient;
0 min;% A solution /% B solution = 100/0 → 30 min;% A solution,% B solution = 40/60
(試験結果)
図3はペンタガロイルグルコピラノースによるαMSH(1−8)生成阻害作用の評価結果である。
(Test results)
FIG. 3 is an evaluation result of αMSH (1-8) production inhibitory action by pentagalloylglucopyranose.
(処方例)
シャクヤク抽出物(製造例1〜3)、及びペンタガロイルグルコースに対して以下処方例を記載するが、本発明の配合に限定したものではない。
(Prescription example)
Although the formulation example is described below with respect to a peony extract (manufacture examples 1-3) and pentagalloyl glucose, it is not limited to the mixing | blending of this invention.
(処方例1)クリーム 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.4−tert−ブチル−4’−メトキシベンゾイルメタン 0.30
3.テトラ2−ヘキシルデカン酸アスコルビル 1.0
4.濃グリセリン 3.0
5.ミツロウ 1.5
6.スクラワン 8.0
7.メチルポリシロキサン 0.30
8.デカメチルシクロペンタシロキサン 4.0
9.パルミチン酸セチル 5.0
10.トリオクタノイン 6.0
11.ベヘニルアルコール 1.0
12.ステアリン酸 2.5
13.キサンタンガム(2%水溶液) 10.0
14.メチルパラベン 適量
15.プロピルパラベン 適量
16.フェノキシエタノール 0.20
17.精製水 全量で100にする
(Formulation example 1) Cream weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2.4-tert-butyl-4'-methoxybenzoylmethane 0.30
3. Ascorbyl tetra-2-hexyldecanoate 1.0
4). Concentrated glycerin 3.0
5. Beeswax 1.5
6). Scrawan 8.0
7). Methylpolysiloxane 0.30
8). Decamethylcyclopentasiloxane 4.0
9. Cetyl palmitate 5.0
10. Trioctanoin 6.0
11. Behenyl alcohol 1.0
12 Stearic acid 2.5
13. Xanthan gum (2% aqueous solution) 10.0
14 Methylparaben adequate amount15. Propylparaben adequate amount 16. Phenoxyethanol 0.20
17. Purify water to 100
(処方例2)W/Oローション 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.L−アルギニン 0.20
3.1,3−ブチレングリコール 10.0
4.メドウホーム油 0.50
5.ホホバ油 0.50
6.カルボマー 10.0
7.トリ 2−エチルヘキサン酸 19.0
8.ペンタ12−ヒドロキシステアリン酸デカグリセリル 2.0
9.メチルパラベン 適量
10.精製水 全量で100にする
(Formulation Example 2) W / O Lotion Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. L-Arginine 0.20
3. 1,3-butylene glycol 10.0
4). Meadow Home Oil 0.50
5. Jojoba oil 0.50
6). Carbomer 10.0
7). Tri 2-ethylhexanoic acid 19.0
8). Decaglyceryl penta 12-hydroxystearate 2.0
9. Methyl paraben Appropriate amount10. Purify water to 100
(処方例3)化粧水 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.クエン酸 0.02
3.クエン酸Na 0.18
4.ペンチレングリコール 3.0
5.コハク酸ジエトキシエチル 15.0
6.精製水 全量で100にする
(Formulation example 3) Lotion weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Citric acid 0.02
3. Na citrate 0.18
4). Pentylene glycol 3.0
5. Diethoxyethyl succinate 15.0
6). Purify water to 100
(処方例4)美容液 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.酢酸dl−α−トコフェロール 0.10
3.パンテノール 0.10
4.L−アルギニン 0.30
5.水溶性コラーゲン 0.10
6.デカマカデミアナッツ脂肪酸ポリグリセリル−10 0.20
7.ヒアルロン酸ナトリウム液 0.50
8.モノオレイン酸ポリグリセリル 1.50
9.1,3−ブチレングリコール 3.00
10.マルトース(75%水溶液) 1.00
11.グリセリン 4.00
12.カルボキシビニルポリマー 11.25
13.エデト酸四ナトリウム 0.10
14.キサンタンガム(2%水溶液) 3.75
15.メチルパラベン 適量
16.フェノキシエタノール 0.20
17.精製水 全量で100にする
(Formulation example 4) Beauty liquid weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Dl-α-tocopherol acetate 0.10
3. Panthenol 0.10
4). L-Arginine 0.30
5. Water-soluble collagen 0.10
6). Decamacademia nut fatty acid polyglyceryl-10 0.20
7). Sodium hyaluronate solution 0.50
8). Polyglyceryl monooleate 1.50
9.1,3-Butylene glycol 3.00
10. Maltose (75% aqueous solution) 1.00
11. Glycerin 4.00
12 Carboxyvinyl polymer 11.25
13. Edetate tetrasodium 0.10
14 Xanthan gum (2% aqueous solution) 3.75
15. Methylparaben adequate amount 16. Phenoxyethanol 0.20
17. Purify water to 100
(処方例5)乳液 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.ヒドロキシプロピルデンプンリン酸 2.0
3.セトステアリルルコール 2.0
4.ステアリン酸ソルビタン 2.0
5.PPG−15ステアリル 4.0
6.トリオクタノイン 5.0
7.トリカプリルグリセリン 5.0
8.ジメチコン 1.0
9.グリセリン 4.0
10.フェノキシエタノール 0.20
11.メチルパラベン 適量
12.精製水 全量で100にする
(Formulation Example 5) Milk weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Hydroxypropyl starch phosphate 2.0
3. Cetostearyl rucol 2.0
4). Sorbitan stearate 2.0
5. PPG-15 stearyl 4.0
6). Trioctanoin 5.0
7). Tricaprylglycerin 5.0
8). Dimethicone 1.0
9. Glycerin 4.0
10. Phenoxyethanol 0.20
11. Methylparaben adequate amount 12. Purify water to 100
(処方例6)美白クリーム 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.縮合リシノール酸ヘキサグリセリル 1.5
3.リン酸L−アスコルビルマグネシウム 3.0
4.精製水素添加大豆リン脂質 0.30
5.1.3−ブチレングリコール 7.0
6.アルギン酸ナトリウム 20.0
7.モノイソステアリン酸ジグリセリル 1.5
8.2−エチルヘキサン酸セチル 7.0
9.メチルフェニルポリシロキサン 5.0
10.グリセリン 8.0
11.メチルパラベン 適量
12.精製水 全量で100にする
(Formulation example 6) Whitening cream weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Hexaglyceryl condensed ricinoleate 1.5
3. L-ascorbyl magnesium phosphate 3.0
4). Purified hydrogenated soybean phospholipid 0.30
5.1.3-Butylene glycol 7.0
6). Sodium alginate 20.0
7). Diglyceryl monoisostearate 1.5
8.2 Cetyl 2-ethylhexanoate 7.0
9. Methylphenylpolysiloxane 5.0
10. Glycerin 8.0
11. Methylparaben adequate amount 12. Purify water to 100
(処方例7)マッサージクリーム 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.水酸化Na 1.0
3.カルボマー 20.0
4.マンナン 8.0
5.ヒマシ油 3.0
6.ジフェニルメチコン 0.05
7.セテアリルアルコール 1.5
8.フェニルトリメチコン 4.5
9.BG 5.0
10.グリコシルトレハロース 8.0
11.グリセリン 3.0
12.メチルパラベン 0.20
13.精製水 全量で100にする
(Formulation example 7) Massage cream Weight%
1. Peonies extract (any one obtained by Production Examples 1-4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Hydroxide Na 1.0
3. Carbomer 20.0
4). Mannan 8.0
5. Castor oil 3.0
6). Diphenylmethicone 0.05
7). Cetearyl alcohol 1.5
8). Phenyltrimethicone 4.5
9. BG 5.0
10. Glycosyl trehalose 8.0
11. Glycerin 3.0
12 Methylparaben 0.20
13. Purify water to 100
(処方例8)ピールオフパック 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.ポリビニルアルコール 15.0
3.ヒドロキシプロピルセルロース 1.0
4.1.3−ブチレングリコール 5.0
5.キトサンPCA 20.0
6.メチルパラベン 0.20
7.エタノール 10.0
8.精製水 全量で100にする
(Formulation Example 8) Peel-off pack Weight%
1. Peonies extract (any one obtained by Production Examples 1-4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Polyvinyl alcohol 15.0
3. Hydroxypropyl cellulose 1.0
4.1.3-Butylene glycol 5.0
5. Chitosan PCA 20.0
6). Methylparaben 0.20
7). Ethanol 10.0
8). Purify water to 100
(処方例9)アフターシェイブローション 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.1−メントール 0.20
3.クエン酸トリエチルヘキシル 1.0
4.ソルビトール 5.0
5.トリエタノールアミン 0.10
6.グリセリン脂肪酸エステル混合物 0.50
7.ヒドロキシプロピルメチルセルロース 2.0
8.グリセリン 3.0
9.カルボマー 0.50
10.ヒマシ油 1.0
11.メチルパラベン 適量
12.精製水 全量で100にする
(Formulation example 9) After shave lotion% by weight
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2.1-Menthol 0.20
3. Triethylhexyl citrate 1.0
4). Sorbitol 5.0
5. Triethanolamine 0.10
6). Glycerin fatty acid ester mixture 0.50
7). Hydroxypropyl methylcellulose 2.0
8). Glycerin 3.0
9. Carbomer 0.50
10. Castor oil 1.0
11. Methylparaben adequate amount 12. Purify water to 100
(処方例10)リキッドファンデーション 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.ペンタイソステアリン酸ポリグリセリル−10 1.5
3.クエン酸トリエチルヘキシル 6.0
4.グルタミン酸ナトリウム 0.50
5.スクラワン 3.0
6.グリセリン 5.0
7.メチルポリシロキサン 0.50
8.デカメチルシクロペンタシロキサン 10.0
9.顔料 15.0
10.メチルパラベン 適量
11.精製水 全量で100にする
(Prescription Example 10) Liquid Foundation Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Polyglyceryl pentaisostearate-10 1.5
3. Triethylhexyl citrate 6.0
4). Sodium glutamate 0.50
5. Scrawan 3.0
6). Glycerin 5.0
7). Methyl polysiloxane 0.50
8). Decamethylcyclopentasiloxane 10.0
9. Pigment 15.0
10. Methylparaben appropriate amount11. Purify water to 100
(処方例11)リップスティック 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.水添オリーブステアリルエステルズ 3.0
3.イソノナン酸イソトリデシル 5.0
4.オレフィンオリゴマー 14.0
5.トリイソステアリン酸ポリグリセリル−2 14.7
6.水添ポリイソブテン 18.0
7.トコフェロール 0.10
8.ポリエチレン 5.0
9.キャンデリラロウ 6.5
10.水添ロジン酸ペンタエリスチル 12.0
11.ヒドロキシアパタイト 1.0
12.マイクロクリスタリンワックス 3.0
13.シリル化シリカ 0.50
14.赤202、トリイソステアリン酸ポリグリセリル−2 0.75
15.酸化チタン、水酸化Al
トリイソステアリン酸ポリグリセリル−2 0.90
16.酸化鉄、トリイソステアリン酸ポリグリセリル−2 1.20
17.青1、トリイソステアリン酸ポリグリセリル−2 0.15
18.酸化チタン、マイカ 5.0
19.プロピルパラベン 0.10
20.イソドデカン 9.0
(Formulation Example 11) Lipstick Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Hydrogenated Olive Stearyl Esters 3.0
3. Isotridecyl isononanoate 5.0
4). Olefin oligomer 14.0
5. Polyglyceryl-2 triisostearate 14.7
6). Hydrogenated polyisobutene 18.0
7). Tocopherol 0.10
8). Polyethylene 5.0
9. Candelilla Row 6.5
10. Hydrogenated pentaerythritol rosinate 12.0
11. Hydroxyapatite 1.0
12 Microcrystalline wax 3.0
13. Silylated silica 0.50
14 Red 202, polyglyceryl triisostearate-2 0.75
15. Titanium oxide, Al hydroxide
Polyglyceryl-2 triisostearate 0.90
16. Iron oxide, polyglyceryl-2 triisostearate-2.20
17. Blue 1, polyglyceryl-2 triisostearate 0.15
18. Titanium oxide, mica 5.0
19. Propylparaben 0.10
20. Isododecane 9.0
(処方例12)アイシャドウ 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.焼成マイカ 10.0
3.パール顔料 50.0
4.ラノリン 2.0
5.ソルビタンセスキオエレート 2.0
6.タルク 3.0
7.流動パラフィン 8.0
8.顔料 5.0
9.香料 適量
10.防腐剤 適量
(Prescription Example 12) Eyeshadow Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Firing mica 10.0
3. Pearl pigment 50.0
4). Lanolin 2.0
5. Sorbitan Sesquio Elate 2.0
6). Talc 3.0
7). Liquid paraffin 8.0
8). Pigment 5.0
9. Perfume appropriate amount10. Preservative appropriate amount
(処方例13)クレンジングオイル 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.コハク酸ジエトキシエチル 3.0
3.ペンチレングリコール 3.0
4.クエン酸Na 適量
5.トリイソステアリン酸ポリグリセリル−2 3.0
6.ジイソステアリン酸PEG−10グリセリル 5.0
7.トリイソステアリン酸PEG−30 15.0
8.ジイソノナン酸ネオペンチルグリコール 1.5
9.精製水 全量で100にする
(Formulation Example 13) Cleansing oil wt%
1. Peonies extract (any one obtained by Production Examples 1-4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Diethoxyethyl succinate 3.0
3. Pentylene glycol 3.0
4). 4. Sodium citrate appropriate amount Polyglyceryl triisostearate-2 3.0
6). PEG-10 glyceryl diisostearate 5.0
7). PEG-30 triisostearate 15.0
8). Neopentyl glycol diisononanoate 1.5
9. Purify water to 100
(処方例14)シャンプー 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.グアーヒドロキシプロピルトリモニウムクロリド 0.10
3.加水分解コラーゲン 0.20
4.PCA 2.0
5.ココイルグルタミン酸K 2.0
6.コカミドDEA 3.0
7.ラウラミドプロピルベタイン、水、塩化Na 4.0
8.ラウリル硫酸TEA 22.0
9.香料 0.10
10.メチルパラベン 適量
11.精製水 全量で100にする
(Formulation Example 14) Shampoo Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Guar hydroxypropyltrimonium chloride 0.10
3. Hydrolyzed collagen 0.20
4). PCA 2.0
5. Cocoyl glutamic acid K 2.0
6). Cocamide DEA 3.0
7). Lauramidopropylbetaine, water, Na chloride 4.0
8). Lauryl sulfate TEA 22.0
9. Fragrance 0.10
10. Methylparaben appropriate amount11. Purify water to 100
(処方例15)コンディショニングシャンプー 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.クエン酸 0.10
3.ポリクオタニウム−10 0.15
4.馬油 1.0
5.PCA−Na 1.0
6.PEG−40水添ヒマシ油 2.50
7.ジアステアリン酸PEG−150 1.0
8.コカミドDEA 4.0
9.コカミドプロピルベタイン 8.0
10.ラウリル硫酸TEA 9.0
11.ラウレス硫酸Na 27.0
12.香料 0.10
13.メチルパラベン 適量
14.精製水 全量で100にする
(Formulation Example 15) Conditioning shampoo Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Citric acid 0.10
3. Polyquaternium-10 0.15
4). Horse oil 1.0
5. PCA-Na 1.0
6). PEG-40 hydrogenated castor oil 2.50
7). Distearic acid PEG-150 1.0
8). Cocamide DEA 4.0
9. Cocamidopropyl betaine 8.0
10. Lauryl sulfate TEA 9.0
11. Laureth sulfate Na 27.0
12 Fragrance 0.10
13. Methylparaben adequate amount14. Purify water to 100
(処方例16)ヘアワックス 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.ジブチルエチルヘキサノイル 3.0
3.ペンチレングリコール 3.0
4.ヒドロキシステアリン酸エチルヘキシル 5.0
5.イソステアリン酸ポリグリセリル−10 1.50
6.ステアリン酸グリセリル 2.0
7.(イソステアリン酸ポリグリセリル−2
/ダイマージリノール酸)コポリマー 4.50
8.水酸化K 0.08
9.ジメチコン 2.0
10.カルボマー 0.30
11.精製水 全量で100にする
(Formulation Example 16) Hair wax Weight%
1. Peonies extract (any one obtained by Production Examples 1-4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Dibutylethylhexanoyl 3.0
3. Pentylene glycol 3.0
4). Ethyl hexyl hydroxystearate 5.0
5. Polyglyceryl isostearate-10 1.50
6). Glyceryl stearate 2.0
7). (Polyglyceryl-2 isostearate
/ Dimerlinoleic acid) copolymer 4.50
8). Hydroxide K 0.08
9. Dimethicone 2.0
10. Carbomer 0.30
11. Purify water to 100
(処方例17)酸性染毛料 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.色素 0.50
3.グリコール酸 5.0
4.コハク酸ビスエトキシジグリコール 5.0
5.ヒドロキシエチルセルロース 2.0
6.エタノール 15.0
7.精製水 全量で100にする
(Formulation Example 17) Acid hair dye Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Dye 0.50
3. Glycolic acid 5.0
4). Bisethoxydiglycol succinate 5.0
5. Hydroxyethyl cellulose 2.0
6). Ethanol 15.0
7). Purify water to 100
(処方例18)ヘアリンス 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.銅クロロフィンNa 0.10
3.加水分解コラーゲン 0.50
4.ステアルトリモニウムクロリド 8.0
5.褐藻エキス 0.20
6.パルミチン酸デキストリン 0.20
7.ジペンタエリスチル 1.0
8.タナクラクレイ 1.0
9.ミネラルオイル 3.0
10.セタノール 5.0
11.オレス−8 2.0
12.クエン酸 0.10
13.香料 0.10
14.メチルパラベン 適量
15.プロピルパラベン 適量
16.ジメチコン 0.50
17.ブチレングリコール 6.0
18.精製水 全量で100にする
(Formulation example 18) Hair rinse weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Copper chlorofin Na 0.10
3. Hydrolyzed collagen 0.50
4). Steartrimonium chloride 8.0
5. Brown algae extract 0.20
6). Dextrin palmitate 0.20
7). Dipentaerystil 1.0
8). Tanakura clay 1.0
9. Mineral oil 3.0
10. Cetanol 5.0
11. Ores-8 2.0
12 Citric acid 0.10
13. Fragrance 0.10
14 Methylparaben adequate amount15. Propylparaben adequate amount 16. Dimethicone 0.50
17. Butylene glycol 6.0
18. Purify water to 100
(処方例19)ヘアトリートメント 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.シラカラバエキス 0.50
3.セージエキス 0.50
4.ステアルトリモニウムクロリド 1.50
5.ジステアルジモニウムクロリド 1.50
6.加水分解コラーゲン 2.0
7.ヒドロキシエチルセルロース 0.10
8.ステアレス−15 1.0
9.ベヘニルアルコール 2.0
10.セタノール 3.0
11.スリチル 1.0
12.メチルパラベン 適量
13.プロピルパラベン 適量
14.ジプロピレングリコール 5.0
15.精製水 全量で100にする
(Prescription Example 19) Hair Treatment Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Birch extract 0.50
3. Sage extract 0.50
4). Steartrimonium chloride 1.50
5. Disteardimonium chloride 1.50
6). Hydrolyzed collagen 2.0
7). Hydroxyethyl cellulose 0.10
8). Steerless-15 1.0
9. Behenyl alcohol 2.0
10. Cetanol 3.0
11. Suritil 1.0
12 Methylparaben appropriate amount13. Propylparaben adequate amount14. Dipropylene glycol 5.0
15. Purify water to 100
(処方例20)ヘアトニック 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.1−メントール 0.05
3.PEGフィトステロール 1.0
4.dl−α−トコフェロール 0.10
5.ヒノキチオール 0.05
6.エタノール 30.0
7.精製水 全量で100にする
(Prescription Example 20) Hair Tonic Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2.1-Menthol 0.05
3. PEG phytosterol 1.0
4). dl-α-tocopherol 0.10
5. Hinokitiol 0.05
6). Ethanol 30.0
7). Purify water to 100
(処方例21)シェービングクリーム 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.TEA 3.0
3.トリオクタイン 2.0
4.ミネラルオイル 4.0
5.キサンタンガム 0.20
6.ジメチコン 0.50
7.ポリソルベート80 2.0
8.ステアリン酸 18.0
9.香料 0.10
10.メチルパラベン 適量
11.ブチレングリコール 8.0
12.精製水 全量で100にする
(Prescription Example 21) Shaving cream% by weight
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. TEA 3.0
3. Trioctane 2.0
4). Mineral oil 4.0
5. Xanthan gum 0.20
6). Dimethicone 0.50
7). Polysorbate 80 2.0
8). Stearic acid 18.0
9. Fragrance 0.10
10. Methylparaben appropriate amount11. Butylene glycol 8.0
12 Purify water to 100
(処方例22)サンスクリーンクリーム 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.アルブチン 3.0
3.ジカプリン酸ネオペンチルグリコール 2.0
4.ヒドロキシステアリン酸フィトステリル 4.0
5.キサンタンガム 0.15
6.ヒアルロン酸Na 1.25
7.スクラワン 8.0
8.ジメチコン 0.5
9.(ジメチコン/ビニルジメチコン)クロスポリマー 1.5
10.シクロペンタシロキサン 5.0
11.ステアリン酸 0.25
12.ステアリン酸PEG−20グリセリル 1.0
13.ステアリン酸ソルビタン 1.0
14.ステアリン酸グリセリン 1.0
15.セテアリルアルコール 1.0
16.エチドロン酸 5.0
17.メチルパラベン 0.20
18.プロピルパラベン 0.05
19.グリセリン 2.0
20.ブチレングリコール 5.0
21.精製水 全量で100にする
(Formulation Example 22) Sunscreen cream% by weight
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Arbutin 3.0
3. Neopentyl glycol dicaprate 2.0
4). Phytosteryl hydroxystearate 4.0
5. Xanthan gum 0.15
6). Hyaluronic acid Na 1.25
7). Scrawan 8.0
8). Dimethicone 0.5
9. (Dimethicone / vinyl dimethicone) Cross polymer 1.5
10. Cyclopentasiloxane 5.0
11. Stearic acid 0.25
12 PEG-20 glyceryl stearate 1.0
13. Sorbitan stearate 1.0
14 Glycerin stearate 1.0
15. Cetearyl alcohol 1.0
16. Etidronic acid 5.0
17. Methylparaben 0.20
18. Propylparaben 0.05
19. Glycerin 2.0
20. Butylene glycol 5.0
21. Purify water to 100
(処方例23)ボディシャンプー 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.スクラワン 0.50
3.ジステアリン酸グリコール 2.0
4.水酸化K 4.70
5.ステアリン酸 3.0
6.ミリスチン酸 4.0
7.ラウリン酸 9.0
8.ラウラミドプロピルベタイン 25.0
9.EDTA−2Na 0.10
10.香料 0.20
11.メチルパラベン 0.30
12.プロピレングリコール 11.0
13.精製水 全量で100にする
(Formulation example 23) Body shampoo% by weight
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Scrawan 0.50
3. Glycol distearate 2.0
4). Hydroxide K 4.70
5. Stearic acid 3.0
6). Myristic acid 4.0
7). Lauric acid 9.0
8). Lauramidopropyl betaine 25.0
9. EDTA-2Na 0.10
10. Fragrance 0.20
11. Methylparaben 0.30
12 Propylene glycol 11.0
13. Purify water to 100
(処方例24)ハンドソープ 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.カリ石ケン素地 10.0
3.ジステアリン酸PEG−150 2.0
4.コカミドDEA 3.0
5.ラウリル硫酸TEA 40.0
6.EDTA−2Na 0.10
7.クエン酸 0.50
8.メチルパラベン 0.10
9.グリセリン 8.0
10.精製水 全量で100にする
(Formulation example 24) Hand soap Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Potash stone base 10.0
3. Distearic acid PEG-150 2.0
4). Cocamide DEA 3.0
5. Lauryl sulfate TEA 40.0
6). EDTA-2Na 0.10
7). Citric acid 0.50
8). Methylparaben 0.10
9. Glycerin 8.0
10. Purify water to 100
(処方例25)液体石鹸 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.ジオレイン酸PEG−120メチルグルコース 1.50
3.ポリオクタニウム−6 1.0
4.オリベム300 2.0
5.オリベム400 8.75
6.ラウラミドプロピルベタイン 6.0
7.カプリロイルグルタミン酸Na 10.0
8.コカミドDEA 1.0
9.香料 0.10
10.メチルパラベン 適量
11.精製水 全量で100にする
(Formulation Example 25) Liquid soap weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Dioleic acid PEG-120 methylglucose 1.50
3. Polyoctanium-6 1.0
4). Olivem 300 2.0
5. Olivem 400 8.75
6). Lauramidopropyl betaine 6.0
7). Capryloyl glutamate Na 10.0
8). Cocamide DEA 1.0
9. Fragrance 0.10
10. Methylparaben appropriate amount11. Purify water to 100
(処方例26)フェイスウォッシュ 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.トコフェロール 0.10
3.グリコシルトレハロース 7.0
4.PEG−75 3.0
5.ジステアリン酸グリコール 2.0
6.ジステアリン酸PEG−150 6.0
7.ラウラミドDEA 4.0
8.水酸化K 6.30
9.ラウラミドプロピルベタイン 15.0
10.ステアリン酸 7.0
11.パルミチン酸 9.0
12.ミリスチン酸 14.0
13.メチルパラベン 適量
14.精製水 全量で100にする
(Formulation Example 26) Face Wash Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Tocopherol 0.10
3. Glycosyl trehalose 7.0
4). PEG-75 3.0
5. Glycol distearate 2.0
6). Distearic acid PEG-150 6.0
7). Lauramide DEA 4.0
8). Hydroxide K 6.30
9. Lauramidopropyl betaine 15.0
10. Stearic acid 7.0
11. Palmitic acid 9.0
12 Myristic acid 14.0
13. Methylparaben adequate amount14. Purify water to 100
(処方例27)入浴剤 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.炭酸水素ナトリウム 39.0
3.香料 1.0
4.デキストリン被覆酸化チタン 9.0
5.乾燥硫酸ナトリウム 全量で100にする
(Formulation example 27) Bath agent weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Sodium bicarbonate 39.0
3. Fragrance 1.0
4). Dextrin-coated titanium oxide 9.0
5. 100% dry sodium sulfate
(処方例28)アクネクリーム 重量%
1.シャクヤク抽出物(製造例1〜3により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.プラセンタエキス 1.0
3.加水分解酵母、 10.0
4.アルギニン 0.80
5.スクラワン 5.0
6.ジメチコン 0.20
7.フェニルトリメチコン 1.0
8.ステアリン酸グリセリル 0.50
9.ステアリン酸 1.0
10.ポリソルベート60 1.50
11.PEG−30 3.0
12.カルボマー 25.0
13.メチルパラベン 適量
14.プロピルパラベン 適量
15.ブチレングリコール 8.0
16.精製水 全量で100にする
(Prescription Example 28) Acne Cream Weight%
1. Peony extract (any one obtained by Production Examples 1 to 3) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Placenta extract 1.0
3. Hydrolyzed yeast, 10.0
4). Arginine 0.80
5. Scrawan 5.0
6). Dimethicone 0.20
7). Phenyltrimethicone 1.0
8). Glyceryl stearate 0.50
9. Stearic acid 1.0
10.
11. PEG-30 3.0
12 Carbomer 25.0
13. Methylparaben adequate amount14. Propylparaben adequate amount15. Butylene glycol 8.0
16. Purify water to 100
(処方例29)練歯磨 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.トラネキサム酸 0.05
3.モノフルオロリン酸ナトリウム 0.73
4.アスコルビン酸−2−リン酸エステルマグネシウム 0.30
5.沈降性シリカ 15.0
6.塩化ナトリウム 5.0
7.水酸化ナトリウム 0.25
8.ラウリル硫酸ナトリウム 1.50
9.カルボキシメチルセルロースナトリウム 0.80
10.カラギーナン 0.60
11.増粘性シリカ 4.0
12.クエン酸 0.10
13.サッカリンナトリウム 0.18
14.香料 1.30
15.70%ソルビット液 45.0
16.プロピレングリコール 3.0
17.精製水 全量で100にする
(Prescription Example 29) Toothpaste Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Tranexamic acid 0.05
3. Sodium monofluorophosphate 0.73
4). Ascorbic acid-2-phosphate magnesium 0.30
5. Precipitated silica 15.0
6). Sodium chloride 5.0
7). Sodium hydroxide 0.25
8). Sodium lauryl sulfate 1.50
9. Sodium carboxymethylcellulose 0.80
10. Carrageenan 0.60
11. Thickening silica 4.0
12 Citric acid 0.10
13. Saccharin sodium 0.18
14 Fragrance 1.30
15.70% sorbite solution 45.0
16. Propylene glycol 3.0
17. Purify water to 100
(処方例30)まつげ用美容液 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.グルコシルヘスペリジン 0.10
3.ヒドロキシエチルセルロース 0.50
4.カルボキシビニルポリマー 1.0
5.エデト酸三ナトリウム 0.02
6.トリエタノールアミン 0.20
7.メチルパラベン 0.20
8.エタノール 5.0
9.1,3−ブチレングリコール 5.0
10.精製水 全量で100にする
(Formulation Example 30) Eyelash serum for weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Glucosyl hesperidin 0.10
3. Hydroxyethyl cellulose 0.50
4). Carboxyvinyl polymer 1.0
5. Edetate trisodium 0.02
6). Triethanolamine 0.20
7). Methylparaben 0.20
8). Ethanol 5.0
9.1,3-Butylene glycol 5.0
10. Purify water to 100
(処方例31)眉毛、まつげ用育毛ジェル 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.EO変性シリコーン 1.0
3.両性ポリマー 1.0
4.カルボキシビニルポリマー 0.50
5.モノイソステアリン酸デカグリセリン 4.0
6.POE(30)イソセチルエーテル 0.50
7.メチルパラベン 0.10
8.亜硫酸水素ナトリウム 0.05
9.エデト酸ニナトリウム 0.05
10.香料 0.5
11.トリエタノールアミン 適量
12.エタノール 10.0
13.精製水 全量で100にする
(Prescription Example 31) Eyebrow, Eyelash Hair Growth Gel Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. EO-modified silicone 1.0
3. Amphoteric polymer 1.0
4). Carboxyvinyl polymer 0.50
5. Decaglycerin monoisostearate 4.0
6). POE (30) isocetyl ether 0.50
7). Methylparaben 0.10
8). Sodium bisulfite 0.05
9. Edetate disodium 0.05
10. Fragrance 0.5
11. Triethanolamine appropriate amount 12. Ethanol 10.0
13. Purify water to 100
(処方例32)制汗スプレー
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.無水エチルアルコール 46.50
3.1,3−ブチレングリコール 1.30
4.ミリスチン酸イソプロピル 1.0
5.香料 0.20
6.LPG 適量
(Prescription Example 32) Antiperspirant spray Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Anhydrous ethyl alcohol 46.50
3. 1,3-butylene glycol 1.30
4). Isopropyl myristate 1.0
5. Fragrance 0.20
6). LPG appropriate amount
(処方例33)タブレット型菓子 重量%
1.乳糖 2.0
2.ビタミンC 3.0
3.クエン酸 1.5
4.ゼラチン1%水溶液 4.0
5.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
6.ショ糖脂肪酸エステル 1.0
7.粉末イチゴ香料 0.5
8.粉糖 全量で100にする
(Prescription Example 33) Tablet type confectionery weight%
1. Lactose 2.0
2. Vitamin C 3.0
3. Citric acid 1.5
4).
5. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
6). Sucrose fatty acid ester 1.0
7). Powdered strawberry flavor 0.5
8). Total powdered sugar to 100
(処方例34)タブレット 重量%
1.微結晶セルロース 30.0
2.カルボキシメチルセルロースカルシウム 24.0
3.ポリビニルピロリドン 10.0
4.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
5.タルク 5.0
6.コーンスターチ 全量で100にする
(Prescription Example 34) Tablet Weight%
1. Microcrystalline cellulose 30.0
2. Carboxymethylcellulose calcium 24.0
3. Polyvinylpyrrolidone 10.0
4). Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
5. Talc 5.0
6). Corn starch to 100
(処方例35)タブレット型健康食品 重量%
1.プロテオグリカン含有サケ鼻軟骨抽出物 4.0
(一丸ファルコス社製,プロテオグリカンF)
2.コンドロイチン硫酸 2.0
3.ヒアルロン酸 0.50
4.N−アセチルグルコサミン 40.0
5.コラーゲンエキスパウダー 7.50
6.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
7.結晶セルロース 9.0
8.ショ糖脂肪酸エステル 3.0
9.微粒酸化ケイ素 2.0
10.マルチトール 全量で100にする
(Prescription Example 35) Tablet-type health food Weight%
1. Salmon nasal cartilage extract containing proteoglycan 4.0
(Proteoglycan F, manufactured by Ichimaru Falcos)
2. Chondroitin sulfate 2.0
3. Hyaluronic acid 0.50
4). N-acetylglucosamine 40.0
5. Collagen extract powder 7.50
6). Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
7). Crystalline cellulose 9.0
8). Sucrose fatty acid ester 3.0
9. Fine silicon oxide 2.0
10. Make all maltitol 100
(処方例36)クッキー菓子 重量%
1.薄力粉 35.0
2.全卵 10.0
3.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
4.バター 20.0
5.砂糖 12.0
6.食塩 10.0
7.ベーキングパウダー 0.30
8.水 全量で100にする
(Formulation example 36) Cookie confectionery weight%
1. Soft flour 35.0
2. Whole egg 10.0
3. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
4). Butter 20.0
5. Sugar 12.0
6). Salt 10.0
7). Baking powder 0.30
8). Make all water 100
(処方例37)カプセル錠 重量%
1.ラクトース 49.0
2.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
3.ステアリン酸マグネシウム 1.0
4.コーンスターチ 全量で100にする
(Prescription Example 37) Capsule Tablet Weight%
1. Lactose 49.0
2. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
3. Magnesium stearate 1.0
4). Corn starch to 100
(処方例38)チューインガム 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.砂糖 53.0
3.ガムベース 20.0
4.水飴 16.0
5.香料 0.50
6.グルコース 全量で100にする
(Formulation Example 38) Chewing gum Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Sugar 53.0
3. Gum base 20.0
4). Minamata 16.0
5. Fragrance 0.50
6). Glucose to 100
(処方例39)グミ 重量%
1.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
2.還元水飴 40.0
3.グラニュー糖 20.0
4.ブドウ糖 20.0
5.ゼラチン 4.70
6.ウメ果汁 4.0
7.ウメフレーバー 0.6
8.色素 0.02
9.水 全量で100にする
(Formulation Example 39) Gummy Weight%
1. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
2. Reduced water tank 40.0
3. Granulated sugar 20.0
4). Glucose 20.0
5. Gelatin 4.70
6). Ume Juice 4.0
7). Ume Flavor 0.6
8). Dye 0.02
9. Make all water 100
(処方例40)清涼飲料 重量%
1.果糖ブドウ糖液 20.0
2.液状ヨーグルト 30.0
3.乳化剤 0.50
4.ヒアルロン酸ナトリウム(分子量5万〜15万) 0.10
5.シャクヤク抽出物(製造例1〜4により得たいずれか) 1.0
(又はペンタガロイルグルコピラノース 0.001)
6.香料 適量
7.精製水 全量で100にする
(Formulation example 40) Soft drink weight%
1. Fructose dextrose solution 20.0
2. Liquid yogurt 30.0
3. Emulsifier 0.50
4). Sodium hyaluronate (molecular weight 50,000-150,000) 0.10
5. Peonies extract (any one obtained by Production Examples 1 to 4) 1.0
(Or pentagalloyl glucopyranose 0.001)
6). Perfume appropriate amount 7. Purify water to 100
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017046987A JP6781901B2 (en) | 2017-03-13 | 2017-03-13 | αMSH (1-8) expression inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017046987A JP6781901B2 (en) | 2017-03-13 | 2017-03-13 | αMSH (1-8) expression inhibitor |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018150270A true JP2018150270A (en) | 2018-09-27 |
JP2018150270A5 JP2018150270A5 (en) | 2019-12-26 |
JP6781901B2 JP6781901B2 (en) | 2020-11-11 |
Family
ID=63680158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017046987A Active JP6781901B2 (en) | 2017-03-13 | 2017-03-13 | αMSH (1-8) expression inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6781901B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111388367A (en) * | 2020-03-25 | 2020-07-10 | 江南大学 | Composition for inhibiting melanin at multiple target points, preparation method and application of composition in cosmetics |
JP2020203845A (en) * | 2019-06-17 | 2020-12-24 | 株式会社クラブコスメチックス | Particulate deposition inhibitor |
-
2017
- 2017-03-13 JP JP2017046987A patent/JP6781901B2/en active Active
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020203845A (en) * | 2019-06-17 | 2020-12-24 | 株式会社クラブコスメチックス | Particulate deposition inhibitor |
JP7427213B2 (en) | 2019-06-17 | 2024-02-05 | 株式会社クラブコスメチックス | Particulate adhesion prevention agent |
CN111388367A (en) * | 2020-03-25 | 2020-07-10 | 江南大学 | Composition for inhibiting melanin at multiple target points, preparation method and application of composition in cosmetics |
CN111388367B (en) * | 2020-03-25 | 2021-09-24 | 江南大学 | Composition for inhibiting melanin at multiple target points, preparation method and application of composition in cosmetics |
Also Published As
Publication number | Publication date |
---|---|
JP6781901B2 (en) | 2020-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010024200A (en) | Promotor for synthesizing biogenic collagen and food, drink, cosmetic and quasi-drug for promoting synthesis of biogenic collagen | |
JP6058532B2 (en) | Composition for inhibiting endothelin-1 production and composition for promoting cell growth | |
WO2019159588A1 (en) | Antipollution agent and topical skin composition | |
JP4286513B2 (en) | Anti-aging composition | |
CN112041329A (en) | Composition for preventing hair loss or promoting hair growth | |
WO2021005941A1 (en) | Albizia julibrissin extract-containing composition | |
JP7428426B2 (en) | Collagen production promoter | |
KR101657082B1 (en) | Pharmaceutical composition for preventing or treating hair loss comprising CXCL1 protein | |
JP6781901B2 (en) | αMSH (1-8) expression inhibitor | |
JP6823889B2 (en) | Composition for anti-aging or skin regeneration containing piperonyl acid as an active ingredient | |
JP2013166785A (en) | Stress-reducing agent of plant origin | |
JP2018150269A (en) | αMSH(1-8) EXPRESSION INHIBITORS | |
JP4587647B2 (en) | Fibroblast growth promoter, skin cosmetics and cosmetics | |
KR101617198B1 (en) | Skin whitening composition containing keratin peptide | |
JP2018150267A (en) | αMSH(1-8) EXPRESSION INHIBITORS | |
JP2006089385A (en) | Composition for beautiful skin | |
JP2021075495A (en) | Anti-inflammatory agent | |
KR101671361B1 (en) | Pharmaceutical composition for preventing or treating hair loss comprising TYMP(thymidine phosphorylase) protein | |
JP2009155305A (en) | New peptide | |
KR102629699B1 (en) | Composition for promoting melanin synthesis comprising pinostrobin | |
US20230321003A1 (en) | Composition for anti-aging or skin regeneration comprising okanin | |
KR102408170B1 (en) | Composition for anti-aging or skin regeneration containing isoprocurcumenol | |
JP2018002702A (en) | Carbonylation inhibitor | |
JP2017095404A (en) | Citrus reticulata extract-containing inositol-trisphosphate receptor expression inducer | |
JP2022011108A (en) | Skin-whitening composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191112 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191112 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200722 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200804 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200820 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200908 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200916 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6781901 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |